Hyperosmolar hyperglycemic state (HHS) — also called HHNS or the older term HHNK — is the most dangerous acute complication of type 2 diabetes. It carries a mortality rate of 15–20%, roughly ten times higher than diabetic ketoacidosis (DKA). Patients lose 8–10 liters of fluid before they reach the emergency department, blood glucose routinely exceeds 800 mg/dL, and altered mental status is the rule rather than the exception. Yet HHS develops over days to weeks, meaning there are multiple missed opportunities to intervene before a patient arrives obtunded.
Understanding HHS is essential for any nurse working in medical-surgical, emergency, or critical care settings. The condition is mechanistically distinct from DKA, requires a specific treatment sequence, and demands vigilant monitoring for a different set of complications. This reference covers the full clinical picture: pathophysiology, precipitating factors, assessment findings, diagnostics, the HHS vs DKA comparison you will see on NCLEX, the treatment protocol, nursing priorities, and the complications that can turn a recovering patient into an emergency.
| HHS quick reference | Detail |
|---|---|
| Full name | Hyperosmolar hyperglycemic state (also HHNS, HHNK) |
| Primary population | Adults with type 2 diabetes; elderly and institutionalized patients at highest risk |
| Glucose threshold | >600 mg/dL (commonly 800–1,200 mg/dL at presentation) |
| Serum osmolality | >320 mOsm/kg (normal: 280–290 mOsm/kg) |
| Ketones | Absent or trace — no significant ketoacidosis |
| pH | ≥7.30 (usually normal; acidosis suggests mixed DKA/HHS or sepsis) |
| Bicarbonate | ≥15 mEq/L |
| Fluid deficit | 8–10 liters (versus 3–6 L in DKA) |
| Onset | Days to weeks (gradual) |
| Mortality | 15–20% — 10× higher than isolated DKA |
| Most common trigger | Infection (UTI, pneumonia, sepsis) |
Pathophysiology
HHS develops from a relative, rather than absolute, insulin deficiency. This distinction is what separates it from DKA and explains the two defining features of the condition: extreme hyperglycemia and the absence of ketoacidosis.
Relative insulin deficiency and hyperglycemia
In type 2 diabetes, endogenous insulin production persists — patients still make insulin, just not enough to fully control blood glucose under physiologic stress. Counterregulatory hormones (glucagon, cortisol, catecholamines, growth hormone) surge in response to a precipitating event such as infection or dehydration. These hormones drive hepatic gluconeogenesis and glycogenolysis, flooding the bloodstream with glucose. Peripheral tissues can’t take up glucose without adequate insulin signaling. Blood glucose climbs, often to 800–1,200 mg/dL.
Osmotic diuresis begins when glucose exceeds the renal reabsorption threshold (~180 mg/dL). Glucose in the urine drags water and electrolytes with it. The kidney excretes sodium, potassium, chloride, phosphate, and magnesium alongside the fluid. A patient who is elderly, institutionalized, or has impaired thirst sensation cannot compensate by drinking — fluid losses accumulate over days to weeks, reaching 8–10 liters by presentation.
Why ketones don’t accumulate
The residual insulin in HHS — even small amounts — is sufficient to suppress lipolysis and ketogenesis at the liver. Fat cells remain partially under insulin’s influence, preventing the massive free fatty acid release that drives ketone production in DKA. Without significant ketone accumulation, blood pH remains normal or near-normal. There is no anion-gap acidosis, no Kussmaul respirations, no fruity breath.
This is the fundamental HHS/DKA distinction. Both involve severe hyperglycemia and osmotic diuresis. HHS does not involve ketoacidosis.
Hyperosmolality and neurological effects
As blood glucose rises and fluid depletes, serum osmolality climbs well above the normal range of 280–290 mOsm/kg. The formula for effective serum osmolality is:
Effective osmolality = 2 × Na⁺ (mEq/L) + glucose (mg/dL) ÷ 18
When osmolality exceeds 320 mOsm/kg, brain cells lose water through osmosis. At 74% of presentations with osmolality in this range, patients have measurable cognitive impairment. At the extreme end, stupor and coma develop. This neurological involvement is what makes HHS uniquely dangerous — and it is driven entirely by hyperosmolality, not by acidosis.
Precipitating factors
Every HHS presentation has a trigger. Identifying and treating that trigger is as important as correcting the metabolic derangement itself.
Infection is the most common precipitant, accounting for approximately 57% of cases. UTI and pneumonia are the leading culprits. Sepsis drives a massive counterregulatory hormone response that overwhelms residual insulin production.
Inadequate fluid intake is particularly relevant in elderly patients, nursing home residents, and anyone with impaired thirst sensation or limited access to fluids. These patients may go days without adequate hydration before the syndrome becomes apparent.
Missed medications or insulin — whether deliberate, accidental, or due to access barriers — removes the partial glycemic control keeping glucose in check.
New-onset or undiagnosed type 2 diabetes — HHS is sometimes the presenting crisis that reveals previously unrecognized diabetes.
Medications that impair insulin secretion or raise glucose:
- Corticosteroids (increase hepatic glucose output and induce insulin resistance)
- Thiazide diuretics (inhibit pancreatic beta cell insulin secretion)
- Atypical antipsychotics, especially olanzapine and clozapine
- Immunosuppressants (tacrolimus, cyclosporine)
Acute medical events — myocardial infarction, stroke, pulmonary embolism, and trauma all trigger counterregulatory hormone surges. HHS may be the presenting crisis, or the acute event may be discovered as the workup proceeds.
Clinical presentation
HHS announces itself differently from DKA. The temporal course is different, the patient population is different, and several key clinical features are absent.
What you will find
Profound dehydration: Dry mucous membranes, poor skin turgor, tachycardia, hypotension, and sunken eyes reflect the massive fluid deficit. Orthostatic hypotension is frequently present. Urine output may have been high earlier in the course (polyuria from osmotic diuresis) but decreases as volume depletion reduces renal perfusion.
Altered mental status: This is the hallmark of HHS. Patients present across a spectrum from mild confusion and disorientation to stupor and frank coma. The degree of mental status change correlates with the degree of osmolality elevation — the higher the osmolality, the more impaired the patient. This is why rapid correction of osmolality is dangerous: if the brain has adapted to a high osmolar environment, too-rapid normalization can cause cerebral edema.
Neurological findings: Beyond diffuse altered mental status, HHS can produce focal neurological deficits, visual disturbances, and seizures. These can mimic stroke and require careful differential diagnosis. Seizures in HHS tend to be focal rather than generalized.
The absence of key DKA findings: There are no Kussmaul respirations (the deep, labored breathing that compensates for metabolic acidosis in DKA). There is no fruity breath (acetone from ketone bodies). Nausea and vomiting are less prominent than in DKA. Abdominal pain is uncommon.
Onset over days to weeks: Patients and family members often describe a gradual decline — increasing confusion over several days, drinking more, urinating frequently, eating poorly. This contrasts sharply with DKA, which typically develops over 24 hours or less.
Diagnostic evaluation
Key laboratory findings
The diagnostic workup for suspected HHS includes a basic metabolic panel, blood glucose, serum osmolality (measured and calculated), urinalysis with urine ketones, serum ketones, and investigation for the precipitating cause.
Serum osmolality: Both measured and calculated values are useful. The calculated effective osmolality (2 × Na⁺ + glucose ÷ 18) reflects the osmotically active particles that affect mental status. Values above 320 mOsm/kg confirm hyperosmolality. Values above 340 mOsm/kg are associated with severe neurological impairment.
Glucose: Typically 600–1,200 mg/dL at presentation. Values above 1,000 mg/dL are not uncommon in elderly patients with prolonged, unrecognized illness.
Sodium: Paradoxically, serum sodium is often falsely low at presentation (pseudohyponatremia from severe hyperglycemia). The corrected sodium formula accounts for this:
Corrected Na⁺ = measured Na⁺ + 1.6 × [(glucose − 100) ÷ 100]
As glucose falls with treatment, corrected sodium should be tracked — if measured sodium rises rapidly as glucose falls, free water deficit is greater than expected.
Potassium: Serum potassium may appear normal or even elevated at presentation despite severe total-body depletion. Volume depletion concentrates extracellular fluid. Once insulin is given and volume is restored, potassium shifts intracellularly and serum levels can fall rapidly. This is the same mechanism as DKA. Check electrolyte management principles for a full review of the potassium-insulin relationship.
BUN and creatinine: Elevated from prerenal acute kidney injury secondary to severe volume depletion. The BUN:creatinine ratio is typically >20:1, consistent with a prerenal pattern. Track these values over the first 24 hours to monitor renal recovery with fluid resuscitation.
pH and bicarbonate: pH typically ≥7.30; bicarbonate ≥15 mEq/L. If pH falls below 7.30 or bicarbonate drops below 15, consider a concurrent metabolic acidosis — either mixed DKA/HHS, lactic acidosis from hypoperfusion, or sepsis-related acidosis.
Ketones: Urine ketones are absent or trace (≤2+ on dipstick). Serum beta-hydroxybutyrate is below 3.0 mmol/L. Significant ketonemia rules out pure HHS and suggests DKA overlap.
CBC with differential: Leukocytosis is common from physiologic stress. A markedly elevated WBC (>25,000) suggests active infection. Obtain blood cultures before antibiotics if sepsis is suspected.
Refer to the nursing lab values cheat sheet for normal reference ranges across all these parameters.
| Lab parameter | HHS expected finding | Clinical significance |
|---|---|---|
| Blood glucose | >600 mg/dL (often 800–1,200) | Diagnostic criterion; drives osmotic diuresis |
| Serum osmolality | >320 mOsm/kg | Correlates directly with neurological impairment |
| Serum sodium | Low, normal, or high — always calculate corrected Na⁺ | Pseudohyponatremia from hyperglycemia is common |
| Serum potassium | Normal or high (total body depleted) | Will fall sharply with insulin; must replace before/during |
| pH | ≥7.30 | Acidosis suggests DKA overlap, sepsis, or lactic acidosis |
| Bicarbonate | ≥15 mEq/L | Below 15 raises concern for concurrent metabolic acidosis |
| Serum ketones (BHB) | <3.0 mmol/L | Elevated = DKA overlap, not pure HHS |
| BUN/creatinine | Elevated, BUN:Cr >20:1 | Prerenal AKI from dehydration; monitor renal recovery |
| WBC | Mildly elevated (stress response) | >25,000 suggests active infection requiring workup |
| Anion gap | Normal to mildly elevated (<12) | Significant elevation suggests DKA or lactic acidosis |
HHS vs DKA: the comparison you need to know
The HHS versus DKA comparison is one of the highest-yield differentials in nursing education. It appears on NCLEX, in clinical vignette questions, and at the bedside in every emergency department. Know every row of this table.
| Feature | HHS | DKA |
|---|---|---|
| Primary diabetes type | Type 2 | Type 1 (can occur in T2DM under stress) |
| Insulin status | Relative deficiency (some insulin present) | Absolute deficiency (no functional insulin) |
| Glucose threshold | >600 mg/dL (often 800–1,200) | >250 mg/dL (typically 300–600) |
| Serum osmolality | >320 mOsm/kg — severely elevated | Variable; osmolality rises but less dramatically |
| Ketones | Absent or trace | Prominent — beta-hydroxybutyrate elevated |
| Arterial pH | ≥7.30 (normal to near-normal) | <7.30 (acidosis, sometimes <7.0 in severe DKA) |
| Bicarbonate | ≥15 mEq/L | <15 mEq/L (sometimes <10 in severe DKA) |
| Anion gap | Normal to mildly elevated | Elevated (>12) — unmeasured ketone anions |
| Onset | Days to weeks (gradual decline) | Hours to 1–2 days (rapid onset) |
| Kussmaul respirations | Absent | Present — compensatory respiratory alkalosis |
| Fruity breath | Absent | Present — acetone exhalation |
| Altered mental status | Hallmark — often profound (stupor, coma) | Variable; correlates with osmolality, not pH |
| Nausea and vomiting | Less prominent | Prominent — GI irritation from acidosis |
| Fluid deficit | 8–10 liters | 3–6 liters |
| Typical age | Older adults; elderly with comorbidities | Any age; most common in young T1DM patients |
| Common trigger | Infection, inadequate fluid intake | Insulin omission, infection |
| Mortality | 15–20% | 0.2–2.5% |
The clinical memory anchor: HHS = no ketones, no acidosis, profound osmolality, profound AMS, elderly patient, gradual onset. DKA = ketones, acidosis, Kussmaul breathing, fruity breath, younger patient, rapid onset.
Treatment
HHS treatment follows a defined sequence: fluids first, then insulin once potassium is confirmed safe, then address the underlying cause. Doing these steps out of order creates preventable harm.
Step 1: aggressive IV fluid resuscitation
Fluid is the most important initial treatment in HHS. Patients arrive with massive volume deficits (8–10 L), and IV fluid alone will reduce blood glucose by 75–100 mg/dL per hour through dilution and improved renal glucose excretion — even before insulin is given.
Initial fluid: 0.9% normal saline (NS) at 500–1,000 mL/hour for the first 1–2 hours. Isotonic saline is preferred initially because it provides volume expansion without creating too-rapid osmolality shifts. In elderly patients or those with known heart failure or renal disease, use smaller initial boluses (250 mL) to avoid volume overload.
Transition fluid: Once hemodynamic stability is restored and corrected sodium is assessed, switch to 0.45% NS at 200–250 mL/hour to provide free water for ongoing hyperosmolality correction.
Rate of osmolality correction: This is a critical safety parameter. Osmolality should not fall faster than 3–8 mOsm/kg/hour. Exceeding this rate risks cerebral edema — the brain has adapted to a high-osmolality environment, and rapid fluid shifts can cause dangerous cerebral swelling.
Dextrose addition: When blood glucose falls to approximately 300 mg/dL, add dextrose (D5W or D5-0.45% NS) to the IV fluid. This maintains glucose at 250–300 mg/dL while fluids continue correcting osmolality. Dropping glucose too rapidly before osmolality is corrected can cause cerebral edema.
Step 2: potassium replacement
Before starting insulin, check serum potassium and confirm it is ≥3.5 mEq/L (some protocols use ≥3.3 mEq/L as the cutoff).
Insulin drives potassium from the extracellular space into cells. In HHS, total-body potassium is already severely depleted despite serum levels that may look normal. If insulin is given when potassium is low or borderline, serum potassium can drop to dangerous levels within 30–60 minutes, triggering arrhythmias. This same principle applies in DKA management.
- If K⁺ ≥3.5 mEq/L: Start insulin; add 20–40 mEq/L KCl to IV fluids
- If K⁺ 3.0–3.4 mEq/L: Replace potassium first; recheck before starting insulin
- If K⁺ <3.0 mEq/L: Hold insulin; aggressively replace potassium; recheck every 1–2 hours
Step 3: insulin therapy
Insulin plays a secondary role in early HHS management — fluids do most of the initial work. Starting insulin too aggressively or before adequate volume is restored can cause rapid glucose drops and unsafe osmolality shifts.
Initial insulin: A fixed-rate IV insulin infusion at 0.05–0.1 units/kg/hour is typical. This is a lower starting dose than DKA protocols, reflecting the goal of gradual, controlled glucose reduction.
Target glucose reduction: 50–75 mg/dL per hour. Faster reduction increases cerebral edema risk.
Transition to subcutaneous insulin: IV insulin is not discontinued until the patient is eating, blood glucose is stable, and osmolality has normalized. Administer subcutaneous basal insulin 1–2 hours before stopping the IV infusion to prevent rebound hyperglycemia.
Step 4: identify and treat the precipitating cause
Every case of HHS has a trigger. The metabolic crisis will recur if the underlying cause is not addressed.
- Obtain blood cultures and urine culture early — before antibiotics if possible
- Start broad-spectrum antibiotics empirically if infection is suspected
- Obtain ECG and troponin to evaluate for myocardial infarction
- Review the medication list for offending agents (steroids, thiazides, antipsychotics)
- Consider CT head if focal neurological deficits suggest stroke
Step 5: DVT prophylaxis
Hyperosmolality increases blood viscosity and creates a hypercoagulable state. Patients with HHS have significantly elevated DVT and pulmonary embolism risk. Unless there is an active contraindication, start pharmacologic DVT prophylaxis (subcutaneous heparin or enoxaparin) promptly and maintain sequential compression devices.
| Treatment phase | Intervention | Key thresholds and parameters |
|---|---|---|
| Fluid resuscitation — initial | 0.9% NS 500–1,000 mL/hr × 1–2 hours | Reduce to 250 mL/hr in elderly or CHF/CKD patients |
| Fluid resuscitation — maintenance | Switch to 0.45% NS at 200–250 mL/hr | Once hemodynamically stable; corrected Na⁺ guides choice |
| Dextrose addition | Add D5W or D5-0.45% NS when glucose ~300 mg/dL | Maintain glucose 250–300 mg/dL while osmolality corrects |
| Potassium check | Confirm K⁺ ≥3.5 mEq/L before insulin | Replace if low; recheck q1–2h during insulin infusion |
| Insulin infusion | 0.05–0.1 units/kg/hr IV | Target glucose drop: 50–75 mg/dL/hr; not >90–120 mg/dL/hr |
| Osmolality correction rate | 3–8 mOsm/kg/hr maximum | Faster correction risks cerebral edema |
| Sodium correction rate | ≤10 mEq/L decline in 24 hours | Track corrected sodium as glucose falls |
| Precipitating cause | Cultures, ECG, troponin, medication review | Treat infection aggressively; recovery depends on it |
| DVT prophylaxis | Subcutaneous heparin or enoxaparin + SCDs | Start promptly; hyperosmolality is hypercoagulable |
| Resolution criteria | Osmolality <310 mOsm/kg; glucose ≤250 mg/dL | Administer SC basal insulin 1–2 hr before stopping IV |
Nursing priorities
Neurological monitoring
Assess and document mental status every 1–2 hours using a standardized tool (GCS or AVPU). Neurological decline during treatment is an emergency — in an adult, it most commonly signals cerebral edema from overly rapid osmolality correction, hypoglycemia, or an unrecognized neurological event (stroke, seizure). In pediatric patients, cerebral edema risk is substantially higher.
Maintain the head of bed at 30–45 degrees for patients with reduced consciousness. Implement seizure precautions. If GCS drops below 8, prepare for airway protection — the patient may no longer be able to protect their own airway.
Cardiovascular and hemodynamic monitoring
Continuous cardiac monitoring is required throughout active treatment. Electrolyte shifts — particularly potassium — cause ECG changes that precede arrhythmias. Hypokalemia produces flattened T waves, U waves, and ST depression. Hyperkalemia causes peaked T waves, widened QRS, and sine wave pattern.
Monitor vital signs every 1–2 hours. Watch for orthostatic hypotension during position changes — these patients are prone to falls from both volume depletion and altered mental status.
Fluid balance
Strict intake and output documentation is non-negotiable. Insert a urinary catheter if the patient is obtunded or unable to reliably report urine output. Target urine output ≥0.5 mL/kg/hour as a sign of adequate renal perfusion.
Track cumulative fluid balance every 4–6 hours. Document all IV fluid administered, oral intake (if any), urine output, and insensible losses. This running total guides decisions about when to reduce fluid administration rates.
Weigh the patient daily. In critically ill patients receiving aggressive fluid resuscitation, daily weight reflects overall fluid status more reliably than any single vital sign.
Laboratory monitoring schedule
During active HHS management, expect the following monitoring intervals:
- Blood glucose: every 1 hour (bedside glucometer; confirm with venous sample every 4 hours)
- Basic metabolic panel (BMP): every 2–4 hours during insulin infusion (sodium, potassium, bicarbonate, BUN, creatinine)
- Serum osmolality: every 2–4 hours until <310 mOsm/kg and mental status improving
- Phosphate and magnesium: every 4–6 hours (deplete with osmotic diuresis; replace as needed)
Skin integrity and fall prevention
Severe dehydration compromises skin integrity — patients with HHS are at high risk for pressure injuries, especially over bony prominences. Reposition every 2 hours, apply barrier cream, and document skin assessment at least daily.
Fall risk is elevated on two fronts: altered mental status and orthostatic hypotension. Use non-skid footwear, bed alarms, and bed in lowest position. Ensure call light is within reach and oriented patients understand the fall risk.
| Nursing priority | System | Key interventions | Frequency |
|---|---|---|---|
| Neurological assessment | Neuro | GCS or AVPU; seizure precautions; HOB 30–45° | Every 1–2 hours |
| Cardiac monitoring | Cardiovascular | Continuous telemetry; ECG changes from K⁺ shifts | Continuous |
| Vital signs | Cardiovascular | HR, BP, orthostatic BP; watch for tachycardia and hypotension | Every 1–2 hours |
| Blood glucose | Metabolic | Hourly glucometer; adjust insulin per protocol | Every 1 hour |
| Electrolytes | Metabolic | BMP with focus on potassium; phosphate and magnesium | Every 2–4 hours |
| Fluid balance | Renal/fluid | Strict I&O; Foley if obtunded; urine output ≥0.5 mL/kg/hr | Hourly urine; cumulative q4–6h |
| Serum osmolality | Metabolic | Track against mental status; rate of fall ≤8 mOsm/kg/hr | Every 2–4 hours |
| Skin integrity | Integumentary | Repositioning; barrier cream; pressure injury prevention | Every 2 hours repositioning; daily skin check |
| Fall prevention | Safety | Bed alarms, non-skid footwear, low bed position, call light in reach | Ongoing |
| Infection workup | Infectious | Cultures before antibiotics; monitor WBC, temperature, signs of sepsis | Ongoing; cultures at admission |
| DVT prophylaxis | Vascular | SQ heparin or enoxaparin; SCDs; early mobility when safe | Per order; SCDs continuously |
| Patient/family education | Discharge planning | Precipitating cause, medication adherence, sick-day rules, when to call | As tolerated; reinforce before discharge |
Complications
Cerebral edema
The most feared complication of HHS treatment. Rapid correction of serum osmolality — particularly from over-aggressive fluid administration — causes water to shift into brain cells that have adapted to a hyperosmolar environment. In adults, cerebral edema during HHS treatment is uncommon but carries high mortality. In pediatric patients, the risk is substantially higher.
Warning signs: new or worsening headache during treatment, sudden neurological deterioration, vomiting, declining GCS, pupillary changes, Cushing’s triad (bradycardia, hypertension, irregular respirations). Immediate interventions include reducing fluid administration rate, elevating the head of bed, and notifying the physician — mannitol or hypertonic saline may be required.
Hypokalemia
The most common life-threatening electrolyte complication during treatment. Insulin drives potassium intracellularly; aggressive volume resuscitation dilutes extracellular potassium. Monitor every 2–4 hours during active insulin infusion and replace promptly. Hypokalemia on ECG (U waves, flattened T waves) requires immediate attention.
Hypoglycemia
Occurs when glucose falls too rapidly or insulin infusion is not adjusted appropriately. Bedside glucometer checks every 60 minutes during active treatment allow timely dose reduction. Adding dextrose to IV fluids at the 300 mg/dL threshold creates a buffer against further rapid drops.
Acute kidney injury
AKI from prerenal causes is present in most HHS patients at admission. Adequate fluid resuscitation typically restores renal function within 24–48 hours. Monitor BUN, creatinine, and urine output closely. Failure of creatinine to improve with fluids suggests intrinsic renal injury or ongoing hypoperfusion.
Thromboembolism
Hyperosmolality, dehydration, and immobility combine to create a hypercoagulable state. DVT and pulmonary embolism risk is significantly elevated. DVT prophylaxis should begin as early as safely possible. Assess lower extremities for signs of DVT (unilateral leg swelling, erythema, pain) daily.
Rhabdomyolysis
Can occur from severe hyperosmolality causing muscle cell injury. Consider checking creatine kinase (CK) in patients with markedly elevated osmolality or who present with myalgias. Rhabdomyolysis can complicate renal recovery and requires additional fluid management.
Patient and family education
Before discharge, patients who are cognitively intact — and their families — need to understand what happened, why, and what to do differently.
Understanding the trigger: Explain what caused this episode in simple terms. If it was a UTI, discuss the importance of recognizing UTI symptoms early. If it was a medication issue, review the medication regimen and address any barriers to adherence.
Sick-day rules: During illness (fever, vomiting, diarrhea), blood glucose rises and fluid losses increase. Patients should:
- Check blood glucose every 4 hours when ill
- Continue diabetes medications and insulin unless the physician advises otherwise
- Increase fluid intake aggressively
- Call the provider if glucose exceeds 300 mg/dL, they cannot keep fluids down, or they feel confused
Hydration habits: Older adults with decreased thirst perception should drink water on a schedule, not just when thirsty. A target of 6–8 glasses of water per day is appropriate for most patients without fluid restrictions.
When to go to the emergency department: Confusion or difficulty thinking clearly, glucose consistently above 500 mg/dL, inability to keep fluids down, extreme fatigue, or any sign of serious illness (high fever, chest pain, difficulty breathing).
Medication adherence and access: Review whether cost, complexity, or logistics contributed to missed medications. Connect patients with social work, patient assistance programs, or pharmacy resources as appropriate.
NCLEX tips
NCLEX tip 1: HHS presents in a type 2 diabetic patient, not type 1. When a question describes an older adult with gradual onset confusion and blood glucose above 600 mg/dL, think HHS.
NCLEX tip 2: The hallmark clinical finding in HHS is altered mental status from hyperosmolality — not Kussmaul breathing or fruity breath. Those are DKA findings. No ketones = no ketoacidosis = no respiratory compensation needed.
NCLEX tip 3: Osmolality calculation will appear on the NCLEX. Memorize: Effective osmolality = 2 × Na⁺ + glucose ÷ 18. A result above 320 mOsm/kg confirms hyperosmolality.
NCLEX tip 4: Always check potassium BEFORE starting insulin — both in DKA and HHS. Insulin drives potassium into cells. If serum K⁺ is already low or borderline and you give insulin, the patient can go into a fatal arrhythmia. Hold insulin if K⁺ <3.5 mEq/L.
NCLEX tip 5: The initial IV fluid is 0.9% normal saline (isotonic) — not 0.45% NS. Isotonic saline expands volume without dropping osmolality too rapidly. The switch to 0.45% NS happens after hemodynamic stabilization.
NCLEX tip 6: Dextrose is added to IV fluids when blood glucose reaches approximately 300 mg/dL — not when glucose is normal. This prevents cerebral edema by maintaining a safe glucose level while osmolality continues to correct.
NCLEX tip 7: The primary difference between HHS and DKA is the presence or absence of ketoacidosis. HHS: no ketones, normal pH, normal bicarb. DKA: ketones present, pH <7.30, bicarb <15. Blood glucose is higher in HHS, but the ketone/pH status is the defining distinction.
NCLEX tip 8: HHS has a much higher mortality than DKA (15–20% vs 0.2–2.5%). If a question asks which hyperglycemic crisis is more dangerous, the answer is HHS.
NCLEX tip 9: Seizures can occur in HHS from severe hyperosmolality. These are often focal seizures, not generalized. Implement seizure precautions for any patient with serum osmolality above 320 mOsm/kg or significant altered mental status.
NCLEX tip 10: DVT prophylaxis is a priority in HHS because hyperosmolality increases blood viscosity and creates a hypercoagulable state. Expect to see this as a nursing priority in NCLEX vignettes.
NCLEX tip 11: The most common precipitating cause of HHS is infection — particularly UTI and pneumonia. A question that gives you an older adult with HHS and a recent upper respiratory illness or urinary symptoms is pointing you toward the trigger.
NCLEX tip 12: In HHS, fluid resuscitation is the primary initial treatment — not insulin. Fluids alone reduce blood glucose by 75–100 mg/dL per hour. Insulin is a secondary intervention, started after volume is partially restored and potassium is confirmed safe.
NCLEX tip 13: Corrected sodium must be calculated in HHS. Hyperglycemia causes false pseudohyponatremia — the sodium appears low but rises appropriately as glucose falls. Use the formula: corrected Na⁺ = measured Na⁺ + 1.6 × [(glucose − 100) ÷ 100].
NCLEX tip 14: Mental status in HHS correlates with serum osmolality. A patient who remains confused despite falling glucose should prompt a check of osmolality — osmolality may still be critically elevated even as glucose is trending down.
Summary
HHS is a true medical emergency with mortality rates that demand rapid, systematic nursing response. The clinical picture — elderly patient with type 2 diabetes, gradual onset, extreme hyperglycemia, absent ketones, profoundly elevated osmolality, and significant altered mental status — distinguishes it clearly from DKA. The treatment sequence follows a defined order: aggressive fluid resuscitation first, potassium confirmation before insulin, controlled glucose and osmolality reduction, and investigation of the underlying trigger.
The nursing role in HHS is intensive: hourly glucose monitoring, frequent electrolyte assessment, vigilant neurological checks, strict fluid tracking, and continuous cardiac monitoring through electrolyte shifts. Understanding the underlying diabetes mellitus and the electrolyte physiology of potassium movement makes the treatment rationale clear and guides safe, confident bedside decision-making.
Written by Lindsay Smith, AGPCNP. Reviewed for clinical accuracy against ADA Consensus Report 2024, NCBI StatPearls HHS reference, and published peer-reviewed literature on hyperglycemic crises.